Rezolute (RZLT) Amortization - Intangibles (2013 - 2014)

Rezolute (RZLT) posted Amortization - Intangibles of $886.0 for Q1 2014, little changed sequentially from $886.0 in Q4 2013.

Analysis

Rezolute (RZLT) Amortization - Intangibles (2013 - 2014) Analysis & Trends

Rezolute has reported Amortization - Intangibles for 2 years, with the latest figure at $886.0 in Q1 2014.

Quarterly Amortization - Intangibles changed N/A year-over-year to $886.0 in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $2953.0 (changed N/A YoY) and the FY2013 annual result came in at $295.0, changed N/A from the prior year.
Amortization - Intangibles held at $886.0 in Q1 2014 per RZLT's latest filing, from $886.0 in the prior quarter.
Over five years, Amortization - Intangibles peaked at $886.0 in Q3 2013 and troughed at $295.0 in Q2 2013.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.62 Bn	131.77 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.73 Bn	77.73 Bn	3.93 Bn
3	Argenx Se	63.53 Bn	58.35 Bn	1.37 Bn
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn
5	Revolution Medicines	44.05 Bn	44.05 Bn	-
6	BeOne Medicines	40.03 Bn	34.93 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.50 Bn	32.19 Bn	992.69 Mn
8	Royalty Pharma	28.52 Bn	27.68 Bn	-
9	Insmed	27.46 Bn	26.30 Bn	358.27 Mn
10	Rezolute	478.07 Mn	478.07 Mn	-

Historic Data

Download Data